ArticleJournal of gastroenterology2026

Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma.

Kazuki Maesaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.